News
The latest AHA Today headline news stories.
A federal district court in Louisiana late yesterday issued a preliminary injunction placing a temporary hold on enforcement of the Centers for Medicare…
The California and San Francisco Departments of Public Health have confirmed the first case of the omicron variant in the United States in an individual in California who was fully vaccinated against COVID-19 and returned Nov. 22 from South Africa, the Centers for Disease Control and Prevention…
Teleflex has recalled a percutaneous thrombolytic device kit due to reports that a component could detach from the device and embolize.
The Food and Drug Administration’s Antimicrobial Drugs Advisory Committee late yesterday voted to recommend an emergency use authorization for Merck’s investigational oral antiviral COVID-19 medicine. The drug, molnupiravir, is meant for the treatment of mild-to-moderate COVID-19 in at-risk adults.
Pfizer yesterday asked the Food and Drug Administration to expand the emergency use authorization for its COVID-19 vaccine booster to include youth aged 16 and 17.
New HIV infections declined among white gay and bisexual men but remained higher and relatively stable among Black/African American and Hispanic/Latino gay and bisexual men between 2010 and 2019, according to a report released yesterday by the Centers for Disease Control and Prevention.
The Centers for Medicare & Medicaid Services last week released two guidance documents to help states and territories maintain Medicaid and Children’s Health Insurance Program coverage for eligible individuals. Access the documents here and here.
Twenty-five organizations, including the AHA, today urged Congress to immediately extend the hold on payment cuts and the private payer data reporting period under the Clinical Laboratory Fee Schedule due to the continued COVID-19 public health emergency.
The Centers for Medicare & Medicaid Services last week released a FAQ clarifying when the Clinical Laboratory Improvement Amendments apply to over-the-counter home tests, including COVID-19 tests.
The Department of Health and Human Services’ Health Sector Cybersecurity Coordination Center (HC3) last week advised biotechnology companies specifically and the health care and public health sector generally to review a new report on a malware threat aggressively spreading through the…